title: Saxagliptin-induced recurrent acute pancreatitis.
abstract: Although dipeptidyl peptidase-4 (DPP-4) inhibitors have been implicated in the development of acute pancreatitis, the causality of this phenomenon is not well established. We herein report the case of an 85-year-old woman who presented with epigastric pain after taking saxagliptin for five months. A high serum lipase level with characteristic computed tomography findings confirmed the diagnosis of acute pancreatitis. The patient's symptoms rapidly resolved after admission, although they recurred when she resumed treatment with saxagliptin for 18 days after discharge. In the absence of any identifiable causes of pancreatitis and considering the temporal sequence of events, the saxagliptin therapy was highly suspected to be the triggering factor. Although drug-induced pancreatitis is rare, treatment with DPP-4 inhibitors should be included as a potential etiology of acute pancreatitis.
authors.affiliation: Department of Internal Medicine, Yuan's General Hospital, Taiwan.
authors.forename: Chien-Feng
authors.initials: CF
authors.lastname: Lee
authors.forename: Meng-Shun
authors.initials: MS
authors.lastname: Sun
authors.forename: Yen-Kuang
authors.initials: YK
authors.lastname: Tai
mesh_terms: D000208:Acute Disease; D000218:Adamantane / Q000009:adverse effects / Q000031:analogs & derivatives*; D000369:Aged, 80 and over; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D004151:Dipeptides / Q000009:adverse effects*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010195:Pancreatitis / Q000139:chemically induced* / Q000175:diagnosis*; D012008:Recurrence
chemical_list: D004151:Dipeptides; D054873:Dipeptidyl-Peptidase IV Inhibitors; C502994:saxagliptin; D000218:Adamantane